Skip to content
Gunilla Osswald and Lars Lannfelt

Image -

Gunilla Osswald and Lars Lannfelt

Simon Hastegård/Bildbyrån
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Simon Hastegård/Bildbyrån
Copyright:
Uppsala University
File format:
.jpg
Size:
6000 x 4000, 3.99 MB
Download

Topics

Contacts

Related content

  • BioArctic’s co-founder Lars Lannfelt and CEO Gunilla Osswald receive the Uppsala University Innovation and Entrepreneurship Award together with co-founder Pär Gellerfors. Photo: Simon Hastegård/Bildbyrån and BioArctic

    Trio behind Alzheimer’s drug receives Uppsala University Innovation and Entrepreneurship Award

    The drug that slows down Alzheimer’s disease is already being used by more than 20,000 patients in 10 different countries – and could soon be available in Europe too. The success story is down to the two founders of BioArctic Lars Lannfelt and Pär Gellerfors and the company’s CEO Gunilla Osswald. Their achievement is now recognised by the Uppsala University Innovation and Entrepreneurship Award.